Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 21, 2025; 31(7): 98806
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98806
Published online Feb 21, 2025. doi: 10.3748/wjg.v31.i7.98806
Figure 4 Modified Pulsatilla decoction alleviates symptoms in intestinal mucositis mice.
A: Percentage of initial body weight (%); B: Diarrhea scores; C: Perianal condition; D: Intestinal length; E: H&E staining (60 × and 200 × magnification); F: Length of the small intestine; G: Length of the colon; H: Histopathological scores; I: MPO expression level. Data are shown as mean ± SD (n = 6-8). aP < 0.01 vs control group; bP < 0.05, cP < 0.01 vs 5-fluorouracil group. 5-FU: 5-fluorouracil; LO: Loperamide; PD: Pulsatilla decoction.
- Citation: Qiu YT, Luo XY, Deng YF, Zheng X, Qiu JG, Zhang LS, Huang XQ, Zheng XB, Huang HY. Modified Pulsatilla decoction alleviates 5-fluorouracil-induced intestinal mucositis by modulating the TLR4/MyD88/NF-κB pathway and gut microbiota. World J Gastroenterol 2025; 31(7): 98806
- URL: https://www.wjgnet.com/1007-9327/full/v31/i7/98806.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i7.98806